REDWOOD CITY, Calif. – Biotricity’s Bioflux cardiac monitoring system has won the MedTech Breakthrough Award 2018 for Best Remote Patient Monitoring Solution. MedTech Breakthrough is an independent organization that recognizes the top companies, technologies and products in the global health and medical technology market, and designed the awards to recognize those companies that have succeeded in pushing ingenuity and exemplify the best healthcare technology solutions across the globe. “We consider this recognition a true testament to the hard work and passion of the Biotricity team and, more importantly, the impact our remote patient monitoring device is expected to have on the lives of patients,” said Waqaas Al-Siddiq, founder and CEO of Biotricity, in a statement. The Bioflux system is designed to be a complete solution for cardiac monitoring and diagnosis, consisting of the Bioflux device, proprietary software and a 24/7 monitoring center that merges with physicians’ existing platforms and workflows, extending the support a patient receives at a care facility into the their home. The device monitors a patient’s ECG in near real-time, constantly analyzing and collecting data on the device and periodically uploading to the cloud via embedded cellular technology.
PLANO, Texas – BrightLife Services is almost ready to launch a new technology for seniors and patients with chronic conditions that connects multiple home health devices to an all-in-one remote monitoring platform.
As a strategic partner and customer of Sensogram Technologies, BrightLife Services is integrating the Sensoscan vitals tracker and Vital Band fall detection smart watch into the platform. It will also incorporate other devices like Bluetooth scales, glucose monitors, smart pill caps and more.
“They’re bringing all the necessary elements together to make virtual care as good as, or better, than an office visit,” said Pete Ianace, corporate development board member of Sensogram Technologies.
BrightLife Services is a device-agnostic home health platform featuring a 10-inch tablet as its hub. The tablet connects to most digital health devices and features artificial intelligence technology, audio/video and voice capabilities, health care and lifestyle apps, and customized educational content for the user’s condition.
The platform connects to a call center for emergencies, as well as to a network of some 9,000 partner health care providers so users get a dedicated care team.
The new platform is expected to launch on June 1.
Ianace said the announcement that Medicare will begin reimbursing physicians for telehealth visits has opened up the market for remote monitoring.
“Remote care hasn’t been effective in the past because there was no way for doctors to be compensated to treat patients at home,” he said. “Now you’re probably going to see 10 more companies doing this kind of service in the next year.”
BrightLife Services will be offered directly to consumers at different levels on a monthly subscription basis—no long-term contracts. The company will send a representative to the user’s home to install and set up the equipment, and then it’s ready go.
‘Technologies available today are finally making true home health care possible’
SAN JOSE, Calif. – VitalConnect is rolling out its Vista Solution remote patient monitoring platform at Mercy Virtual and Mercy Hospital St. Louis, with plans to implement the technology at additional hospitals within the health system.
“This is a huge step in providing high-quality care both in and outside of the hospital,” said Nersi Nazari, CEO of VitalConnect.
The Vista Solution platform continuously monitors and displays real-time vital sign data, out-of-range notifications and historical data to health care providers. It works with the VitalPatch biosensor, a bandage-sized device worn by the patient that allows wireless health monitoring.
Nazari said the time is right for technology like VitalConnect’s.
“Home health care has not been reasonably scalable with modern day medicine until now,” he said. “Technologies available today are finally making true home health care possible in an economical way.”
A recent randomized study from Brigham & Women’s Hospital using the VitalPatch biosensor found a 52% reduction in the acute-care episode of care, including 30 days post-discharge, and a 67% reduction in total costs.
“This trend of lowering costs, while providing quality alternatives to expensive hospital care, is important for the health care industry at large and will help drive the largest shift that we have seen in decades,” said Nazari. “Devices that can passively collect data and monitor a patient while they rest and recover are critical to delivering this care, as well as keeping costs down.”
With the remote patient monitoring market estimated to be worth $15 billion and expected to double in the next five years, Nazari said the type of monitoring that VitalConnect offers will increasingly become the standard of care.
“We are seeing innovative health care systems adopt these cutting-edge monitoring technologies and they will pave the way for the rest of the country,” he said.
VANCOUVER, British Columbia – Reliq Health has expanded its contract with Texas-based Paz Home Health to provide its iUGO Care remote patient monitoring and telemedicine solution. The revised contract increases the number of Paz Home Health subscribers by 5,000 patients, bringing the total to more than 15,000 patients. “Paz Home Health has successfully demonstrated the benefits of using Reliq’s iUGO Care remote patient monitoring system to improve health outcomes and reduce hospital admissions and ER visits in their patients,” said Dr. Lisa Crossley, CEO of Reliq Health, in a statement. Paz Home Health leveraged Reliq Health’s iUGO technology to achieve Approved Provider status for in-home telemonitoring from Superior HealthPlan, a managed care organization that works with the State of Texas Health and Human Services Commission to deliver care through approved providers to Medicare and Medicaid patients. Paz Home Health provides care to patients across 16 counties in southern Texas.
CINCINNATI – CHI Health at Home will use technology from HomeCare Vitals to provide advanced remote care management of patients with congestive heart failure, chronic obstructive pulmonary disease and diabetes.
“What we hope to demonstrate very quickly is that our technology is not only the most patient-affordable solution on the market today, but that it will also allow CHI Health at Home to achieve unprecedented clinical outcomes for its vast network of chronic care patients, which is in keeping with CHI’s commitment to patient-centered, affordable care,” said Dr. Suresh Nayak, co-founder of HomeCare Vitals, in a statement.
HomeCareVitals technology is flexible, scalable and capable of remotely monitoring any patient population, Nayak said. It can also be tailored to meet individual patient needs at all levels of technology expertise and comfort.
In pilot testing, the technology was shown to reduce readmissions by as much as 65% and patient compliance and satisfaction rates reached 95%.
“As we deliver care under an increasingly risk-based reimbursement model, we are excited to become a development partner in HomeCareVital’s scalable population health management technology,” said Rodney Plunkett, vice president of population health management at CHI Health at Home, in a statement. “Supporting trialed innovative technologies that solve critical health care problems is at the heart of our mission at CHI Health at Home.”
CHI Health at Home provides home care and supplemental staffing, hospice, home respiratory care, home infusion therapy and medical transportation in more than 50 locations across eight states.
HUDSON, N.Y. – YouThisMe has expanded its remote patient monitoring technology platform to support iOS-compatible biometric devices, including pulse oximeters made by Nonin Medical, and digital scales and blood-pressure cuffs from A&D Company. YouThisMe also enhanced the security of its platform and implemented design improvements to the user interface. “We have created a greater level of choice and flexibility for providers that are implementing remote patient monitoring systems for their patient populations,” said Seth Lachterman, a partner and co-founder of YouThisMe, in a statement. “By using these biometric devices, which connect to a smartphone or tablet computer through a Bluetooth, low-energy wireless interface, the YouThisMe platform is able to read patients’ vital signs directly, without the need for a third-party app.” YouThisMe’s integrated software and hardware solution helps providers manage the vital signs of homebound, chronically ill patients. The company also recently partnered with Denmark-based OpenTelehealth to develop a platform with the iOS mobile operating system.
SANTA MONICA, Calif. – As part of an expanded relationship, Accredited Home Care, a provider of home health care and nursing services, will add Parallax Health Management’s Good Health Outcomes telehealth platform to its remote patient care program serving more than 35,000 patients.
”Accredited has been a client of Parallax for over two years, and we are excited that they have decided to expand their telehealth and remote patient monitoring services with our next generation connected health platform Good Health Outcomes,” stated Paul Arena, CEO of Parallax, in a statement. “Our mutual goals are to deliver our connected health products and services to 30% of their patient population in the first 12 months of our agreement, and 70% by the end of 24 months.”
Parallax Health Management has also announced a contract with telehealth company Uni Care Home Health to deploy the Good Health Outcomes platform to address the growing needs of Uni Care’s patient population and increased insurance reimbursements related to their remote patient care business.
”Our system reduces the costs related to hardware and logistics associated with our competitors while increasing data capture, quality and analytics capabilities,” said Nathan Bradley, chief technology officer at Parallax Health Management, in a statement. ”My team continues to make progress in the reduction to practice of our patented and patent pending solutions, converting concept to realization, resulting in an increase in our client’s operational efficiencies, service expansion and patient satisfaction. Our capabilities are generating a market separation from our competitors.”
Uni Care is a provider of home health and telehealth services within the San Diego and Riverside counties in California.
“Parallax enables us to reduce our costs of care delivery while increasing the quality of life for our patients coping with chronic disease management and acute rehabilitation,” said Albert Keshavrzi, CEO of Uni Care, in a statement.
LOS ANGELES – Remote patient monitoring may not improve some clinical outcomes, according to a study published recently in Nature Digital Medicine.
In the study, researchers from Cedars Sinai Medical Center examined previous clinical trials that used wearable biosensors for remote monitoring to see if improved outcomes were achieved.
“Despite growing interest in remote patient monitoring, limited evidence exists to substantiate claims of its ability to improve outcomes,” wrote Benjamin Noah, first author of the study.
More than 4,000 previously published articles were collected for the review, and 16 were selected as high-quality studies in their examination of wearable biosensors for remote patients monitoring.
Results of the study showed no statistically significant impact in using remote patient monitoring in clinical outcomes of body mass index, weight, waist circumference, body fat percentage, systolic blood pressure and diastolic blood pressure.
Remote patient monitoring showed early promise, however, for patients with certain conditions, including chronic obstructive pulmonary disease, Parkinson’s disease, hypertension and low back pain, the researchers found.
“Although some consumer-facing digital health products may be effective for promoting behavior change, there is currently a dearth of evidence that these devices achieve health benefits,” Noah wrote. “More research is needed in this field.”
The team concluded that future studies should be powered to analyze sub-populations to better understand when and for whom RPM is most effective, and that patients, clinicians and health system leaders should proceed with caution before implementing and using RPM to reliably change clinical outcomes.
“For RPM interventions to impact healthcare, they will need to impact outcomes that matter to patients,” Noah wrote.
REDWOOD CITY, Calif. — Health care technology company Biotricity is working with a proof of concept version of its remote patient monitoring hardware embedded with artificial intelligence as it seeks to differentiate itself in the growing remote monitoring marketplace. “We plan on implementing artificial intelligence at the device level to maximize detection and accuracy while increasing efficiency,” said Waqaas Al-Siddiq, founder and CEO of Biotricity, in a statement. “We expect our next generation Bioflux device with artificial intelligence capabilities to be the first of its kind in the RPM marketplace.” The company plans to file an additional hardware clearance with the U.S. Food and Drug Administration this year, before launching the next version.
ST. LOUIS, Mo. – Health care startup Epharmix is building on its clinically proven SMS-based adherence technology and looking to scale up as quickly as possible.
Epharmix uses automated text messages and phone calls to help people with chronic diseases better manage their condition and improve outcomes.
“We’re just going to continue to advance the research and build out our portfolio,” said Jason Roche, growth engineer at Epharmix, which is currently partnering with several large health systems.
The company was recently selected as one of seven health care startups for Dreamit Health’s ninth cohort. The 14-week accelerator program provides one-on-one coaching, opportunities to pitch to dozens of potential customers, meet with top-tier venture funds and gain access to a network of Dreamit alumni and other resources.
Epharmix’s technology has been clinically proven to drive lasting patient engagement and improve adherence through several published papers including the Journal of Medical Internet Research, Scientific Reports and JMIR Diabetes.
“Patients don’t always have the time to troubleshoot Bluetooth devices or walk through new mobile applications,” said Roche. “Our technology collects patient-reported outcomes in a form patients and providers understand most—phone calls and text messages.”
Epharmix’s system automatically collects biometrics and symptoms for 24 disease states and several chronic conditions. Roche said the technology is currently being used in 10 different states and is live on 100 platforms, with a focus on medically underserved patients in the home who are hard to engage.
“The technology is helping health care to move into a ‘true value’ space,” Roche said. “With increasing connectivity, clinicians can oversee more patients.”